Pfizer to Pay $35 Million For Promoting Off-Label Use of Drug
Pfizer Promoting Off-Label Use of Drug. Drug maker Pfizer will pay $35 million to North Carolina and 41 other states to resolve allegations that it unlawfully promoted the drug Rapamune. The 42 Attorneys General allege that Wyeth Pharmaceuticals Inc., a Pfizer subsidiary, engaged in unfair and deceptive practices by … [Read more...]
Avastin Eye Treatment Infections
Eye Infections Linked to Avastin Eye Treatment. An off-label use of the cancer drug Avastin has been linked to serious eye infections that, in some cases, have resulted in permanent blindness. All of these eye infections occurred in people who received Avastin injections in the eye to treat wet age-related macular … [Read more...]
Malaria Drug Puts Blood Disorders Risk
Malaria Drug Risk For Blood Disorder. U.S. health regulators warned today that people who use the malaria drug Qualaquin to treat night time leg cramps face a serious risk of life-threatening blood disorders. AR Scientific, which distributes Qualaquin in the U.S., has developed a risk management plan aimed at educating health care … [Read more...]
Off-Label Use of Rituxan Linked to Fatal Leukoencephalopathy
FDA is Warning Healthcare Professionals Regarding the Risk for PML Patients Receiving Rituxan. The US Food and Drug Administration (FDA) is warning healthcare professionals regarding the risk for progressive multifocal leukoencephalopathy (PML) in patients receiving rituximab intravenous infusion (Rituxan, made by Genentech, Inc, and … [Read more...]
